Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | RORA | P35398 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | RORB | Q92753 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NPY1R | P25929 | 1/20 | 0.34 |
| ▸ | NPY2R | P49146 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13555375 | 0.84 | GPR3 (0.36) | GPR3CYP1A2CYP2C19PGRRORA | |
| SCHEMBL13954491 | 0.80 | GPR3 (0.39) | GPR3GPR84CYP1A2CYP2C19BACE1 | |
| SCHEMBL23680180 | 0.79 | GPR3 (0.38) | GPR3CYP1A2CYP2C19BACE1ALDH1A1 | |
| SCHEMBL25823736 | 0.77 | DNM1 (0.49) | GPR3CYP1A2CYP2C19BACE1ALDH1A1 | |
| SCHEMBL574039 | 0.77 | GPR3 (0.43) | GPR3FFAR1GPR84CYP1A2CYP2C19 | |
| SCHEMBL21030063 | 0.76 | GPR3 (0.39) | GPR3CYP1A2CYP2C19PGRRORA | |
| SCHEMBL13772400 | 0.76 | CNR1 (0.43) | GPR3CYP1A2CYP2C19PGRRORA | |
| SCHEMBL25526924 | 0.74 | GPR3 (0.40) | GPR3FFAR1GPR84CYP1A2CYP2C19 | |
| SCHEMBL4729183 | 0.74 | GPR3 (0.40) | GPR3FFAR1GPR84CYP1A2CYP2C19 | |
| SCHEMBL18597053 | 0.72 | GPR3 (0.46) | GPR3CYP1A2CYP2C19BACE1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4329431-A2 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXES | Universal Display Corporation (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-3882254-B1 | PHOSPHORESCENT HOMOLEPTIC TRIS-[DEUTERATED-2(2-PYRIDINYL)PHENYL]-IRIDIUM COMPLEXES FOR USE IN LIGHT-EMITTING DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-10-04 | — | — | EP | disclosed |
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
| EP-4223854-A2 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2023-08-09 | — | — | EP | disclosed |
| EP-3424934-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-07-14 | — | — | EP | disclosed |
| EP-3505524-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-07-07 | — | — | EP | disclosed |
| EP-3220441-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3547387-A1 | ELECTROLUMINESCENT ELEMENT | Universal Display Corporation (US) | 2019-10-02 | — | — | EP | disclosed |
| EP-3505524-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2019-07-03 | — | — | EP | disclosed |
| EP-2910555-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORP (US) | 2019-03-27 | — | — | EP | disclosed |
| EP-3309155-A1 | HOST MATERIALS FOR PHOLEDS | Universal Display Corporation (US) | 2018-04-18 | — | — | EP | disclosed |
| EP-2857409-B1 | Novel Heteroleptic Iridium Complexes | UNIVERSAL DISPLAY CORP (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-2329544-B1 | WHITE PHOSPHORESCENT ORGANIC LIGHT EMITTING DEVICES | UNIVERSAL DISPLAY CORP (US) | 2017-05-17 | — | — | EP | disclosed |
| EP-2874195-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORP (US) | 2017-05-03 | — | — | EP | disclosed |
| EP-2718302-B1 | HETEROLEPTIC IRIDIUM CARBENE COMPLEXES AND LIGHT EMITTING DEVICE USING THEM | UNIVERSAL DISPLAY CORP (US) | 2017-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, PDCD1LG2, NECTIN4 | GPR3 3220/4885FFAR1 4634/4885GPR84 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.